- abnormal cranium morphology / IMPC
- decreased body weight / IMPC
- increased circulating HDL cholesterol level / IMPC
- abnormal skin morphology / IMPC
- increased circulating cholesterol level / IMPC
- increased circulating total protein level / IMPC
- decreased NK cell number / IMPC
- enhanced cued conditioning behavior / IMPC
C57BL/6NCrl-Sla2em1(IMPC)Ccpcz/Ph
Status | Available to order |
EMMA ID | EM:12418 |
International strain name | C57BL/6NCrl-Sla2em1(IMPC)Ccpcz/Ph |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Sla2em1(IMPC)Ccpcz |
Gene/Transgene symbol | Sla2 |
Information from provider
Provider | Institute of Molecular Genetics |
Provider affiliation | Department of Transgenic Models of Diseases, Institute of Molecular Genetics |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institute of Molecular Genetics, Prague, Czech Republic |
Animals used for archiving | heterozygous C57BL/6NCrl |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased NK cell number / IMPC
- increased circulating total protein level / IMPC
- decreased body weight / IMPC
- increased circulating HDL cholesterol level / IMPC
- enhanced cued conditioning behavior / IMPC
- abnormal skin morphology / IMPC
- abnormal cranium morphology / IMPC
- increased circulating cholesterol level / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).